Kevin was a research technician with the Bernt lab (2018-2022). He graduated from Penn State with a B.S in Biotechnology. In the Bernt lab, Kevin’s project is focused on profiling the global chromatin landscape in patient samples, hoping to understand what the differences are among AML subgroups. He also is a tech in the Aplenc lab where they are interested in discovering novel targets on the surface of AML cells for immunotherapy. Outside of the lab, Kevin enjoys live music, sports, hiking and biking. He is now pursuing graduate studies at George Washington University!